Insys Therapeutics
Mar 30, 2017
Mylan closing Illinois plant; Insys spends $24M; Roche’s Ocrevus; Greece’s corruption prosecutor quits
Mylan closing Illinois plant, cutting 90 jobs as part of slim-down after Meda buyout Mylan has been in the midst of cutting about 3,500 jobs to decrease costs and refocus after its $7 billion buyout last year of Meda Pharmaceuticals. About 90 of those cuts will come with the closure of a plant in Illinois.The drugma...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
